PRESS RELEASE

BON ANTARES VISION PROCEDURES AND EXERCISE RATE

Travagliato (BS), November 2, 2021 – Antares Vision SpA (“Antares Vision” or the “Company”) announces that, in accordance with article 3 of the Regulations for the “Mandates of Antares Vision SpA” (respectively, the “Regulations on the mandates ”1 and the “Warrants”), the average monthly price for October 2021 is 11,150 euros (source FactSet, average monthly price calculated as the arithmetic average of the official prices of the ordinary shares of Antares Vision SpA on the October trading days ).

Consequently, the Exercise Price being 9.50 euros and the Subscription Price of the Conversion Shares of 0.10 euros, the Exercise Ratio for November 2021 is 0.1466.

Any request to exercise the Warrants must be submitted to the broker who is a member of the centralized management system of Monte Titoli SpA, where the Warrants are deposited, before the Last Trading Day in November 2021. The Company will make the corresponding Conversion Shares available. for trading purposes, through Monte Titoli SpA, on the next settlement day at the end of November 2021. The conversion shares will have the same dividends as the ordinary shares on the effective exercise date of the Warrants.

The Subscription Price must be paid in full to the Company’s current account indicated below when submitting the exercise request:

IBAN

FAST

IT 59V 05387 11236 000042573777

BPMOIT22XXX

In all cases where, at the time of exercise of the Warrants, a fractional number of Conversion Shares is due, the holder of Warrants will be entitled to receive Conversion Shares up to the amount of the immediately lower whole number and n ‘will have no rights with respect to the excess fractional part.

At the time the exercise request is submitted, the holder of the Warrants will acknowledge that the Conversion Shares granted in connection with the exercise of the Warrants have not been registered in accordance with the Securities Act of 1933, as amended, in force. in the United States of America.

Antares Vision also announces that in October, no exercise requests were received. As a result, the share capital of Antares Vision (equal to 169,419.24 euros, divided into 69,105,497 ordinary shares, 250,000 Special Shares and 1,189,590 Performance Shares, with no indication of nominal value for any category) remained unchanged as well as the outstanding warrants (equal to 2,550,706).

For any additional information, please refer to the BSA Regulations available on the Antares Vision website www.antaresvision.com – “Investors – Investor Relations – Warrant“section.

  • The terms indicated in this press release with a capital letter have the same meaning as those contained in the Warrants Regulations.

PRESS RELEASE

ABOUT THE ANTARES VISION GROUP

Listed since April 2019 on the Italian Stock Exchange on the AIM market, and from May 14, 2021 on the STAR segment of Mercato Telematico Azionario (MTA), the Antares Vision group guarantees the protection of products, profits, people and planet through inspection systems for quality control. , Track & Trace solutions for the fight against counterfeiting and supply chain transparency, intelligent data management tools for maximum efficiency and the digitization of the entire supply chain, raw materials to the end consumer. The Antares Vision Group is active in the pharmaceutical market and in Life Sciences in general (biomedical devices and hospitals), in beverages, food, cosmetics and consumer goods. The Group reaches more than 60 countries in the world with complete and flexible solutions, hardware and software, with associated services and has 7 production sites in Italy (Brescia, Parma, Piacenza, Latina, Padua and Vicenza), 22 foreign subsidiaries (Germany [2], France [2], UNITED STATES [5], Brazil [2], UK [2], India, Russia [3], Hong Kong, China, Ireland, Croatia and Serbia), 3 Innovation and Research Centers (Italy) and a global network of more than 40 partners. Thanks to the twenty years of experience in vision technologies of the two founding partners, the Antares Vision Group is the supplier of 10 of the 20 largest pharmaceutical companies in the world, with more than 25,000 inspection systems, which guarantee safety and day-to-day product quality, 6,500 quality controls and more than 3,500 serialization modules on lines installed around the world. In order to pursue and support the growth and development strategy, during the year 2019, participation agreements were finalized with T2 Software, a Brazilian company specializing in intelligent data management solutions, and Orobix , an Italian company leader in artificial intelligence services, as well as the acquisition of 100% of FT System, leader in control and inspection in the beverage sector. In 2020, Antares Vision acquired 82.83% of Tradeticity, a Croatian company specializing in software management of traceability and serialization processes, 100% of Convel, an Italian company specializing in automated inspection machines for the pharmaceutical industry, the assets of Adents High Tech International, a French company specializing in serialization and traceability software, 100% of Applied Vision, world leader in inspection systems for glass and metal containers in the food industry. In March 2021, Antares Vision acquired 100% of rfXcel Corporation, specializing in US-based supply chain scanning and transparency software solutions, and 100% of Pen-Tec and Tecnel, through FT System, increasingly specializing in the food and beverage inspection industry. . Further information is available at www.antaresvision.com and at www.antaresvisiongroup.com.

PRESS RELEASE

For more information

ISSUER

ANTARES VISION S.P.A.

VIA LED FFAULT, NOT. 16

25039 – TRAVAGLIATO (BS)

ALESSANDRO BA J BADINO (IINVESTOR RELATOR)

TEL.: +39 030 72 83 500

E-MAIL: INVESTORS@ANTARESVISION.COM

RI consultant

IR TOP VSCONSULTATION

VHAVE BIGLI,NOT. 19

20121 – MILANO

TEL.: +39 02 45473884

MARIA ANTONIETTA PIREDDU

E-MAIL: M.PIREDDU@IRTOP.COM

ANTONIO BUOZZI

EMAIL: [email protected]

Disclaimer

Antares Vision SpA published this content on November 02, 2021 and is solely responsible for the information it contains. Distributed by Public, unedited and unmodified, on 02 November 2021 17:49:04 UTC.

Public now 2021

All news on ANTARES VISION SPA
Sales 2021 183 million
212 million
212 million
Net income 2021 18.3 million
21.2 million
21.2 million
Net debt 2021 25.6 million
29.7 million
29.7 million
PER 2021 ratio 43.2x
Yield 2021 0.40%
Capitalization 829 million
961 million
960 million
VE / Sales 2021 4.66x
VE / Sales 2022 3.83x
Number of employees 927
Free float 25.9%

ANTARES VISION SPA card
Duration :

Period:

Antares Vision SpA Technical Analysis Chart |  MarketScreener

Trends in technical analysis ANTARES VISION SPA

Short term Mid Road Long term
Tendencies Bullish Neutral Neutral

Evolution of the income statement

To sell

To buy

Average consensus SURPASS
Number of analysts 3
Last closing price

€ 12.00

Average price target

€ 13.93

Spread / Average target 16.1%


Source link